Addex and Dystonia Medical Research Foundation Announce Partnership to Explore the Therapeutic use of Dipraglurant in ...

Geneva, Switzerland /Chicago, USA, 19 January 2015 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development and the Dystonia Medical Research ...



from Content Keyword RSS http://ift.tt/1BSdbXo

via IFTTT